NCT03183674View on ClinicalTrials.gov

Oxytocin in Spectrum Autism Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 15, 2016

Primary Completion Date

July 20, 2017

Study Completion Date

May 15, 2018

Conditions
Autistic Disorder
Interventions
DRUG

Oxytocin

Single dose oxytocin 45 minutes before the test

OTHER

placebo

saline solution 0,9% spray nasal

Trial Locations (1)

04117-130

Instituto de Psiquiatria, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT03183674 - Oxytocin in Spectrum Autism Disorders | Biotech Hunter | Biotech Hunter